Actavis Sued Over Generic Oleptro Plans

Law360, New York (August 23, 2012, 1:30 PM EDT) -- Italian drugmaker Aziende Chimiche Riunite Angelini Francesco Acraf SpA hit rival Actavis South Atlantic LLC with a patent infringement suit in Delaware federal court Tuesday over Actavis' plans to make a generic version of antidepressant Oleptro.

Actavis notified Angelini in July that it had submitted an abbreviated new drug application to the U.S. Food and Drug Administration, seeking to manufacture 150- and 300-milligram dosages of trazodone hydrochloride tablets, the generic equivalent of Oleptro, the complaint said.

Oleptro, marketed in the U.S. by Angelini and Labopharm Inc....
To view the full article, register now.